ESC Premium Access

Discussant review - SWEDEHEART

Congress Presentation

About the speaker

Professor Volkmar Falk

Deutsches Herzzentrum der Charite (DHZC), Berlin (Germany)
25 presentations
0 follower

12 more presentations in this session

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommended therapies. Final 5-year results from the CLARIFY study

Speaker: Doctor E. Sorbets (Paris, FR)


Discussant review - CLARIFY

Speaker: Professor D. Hasdai (Petah Tikva, IL)


Questions from the audience and discussion


SWEDEHEART - Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Speaker: Doctor E. Bjoerklund (Gothenburg, SE)


Questions from the audience and discussion


Access the full session

Hot Line Session 5

Speakers: Professor V. Falk, Doctor E. Sorbets, Professor D. Hasdai, Doctor E. Bjoerklund

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb